Compare ALEMBIC PHARMA with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA J.B.CHEMICALS ALEMBIC PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 17.5 38.5 45.4% View Chart
P/BV x 6.9 7.2 96.9% View Chart
Dividend Yield % 0.5 0.2 334.4%  

Financials

 ALEMBIC PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
J.B.CHEMICALS
Mar-18
ALEMBIC PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs664363 182.9%   
Low Rs412255 161.7%   
Sales per share (Unadj.) Rs208.7169.1 123.4%  
Earnings per share (Unadj.) Rs31.016.6 186.7%  
Cash flow per share (Unadj.) Rs37.123.4 158.5%  
Dividends per share (Unadj.) Rs5.502.00 275.0%  
Dividend yield (eoy) %1.00.6 157.9%  
Book value per share (Unadj.) Rs144.2172.5 83.6%  
Shares outstanding (eoy) m188.5283.57 225.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.61.8 141.1%   
Avg P/E ratio x17.418.6 93.3%  
P/CF ratio (eoy) x14.513.2 109.9%  
Price / Book Value ratio x3.71.8 208.3%  
Dividend payout %17.712.0 147.3%   
Avg Mkt Cap Rs m101,46125,827 392.8%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m7,4672,511 297.4%   
Avg. sales/employee Rs ThNM3,747.4-  
Avg. wages/employee Rs ThNM665.7-  
Avg. net profit/employee Rs ThNM367.8-  
INCOME DATA
Net Sales Rs m39,34714,135 278.4%  
Other income Rs m94366 25.6%   
Total revenues Rs m39,44114,501 272.0%   
Gross profit Rs m8,7362,178 401.0%  
Depreciation Rs m1,152570 202.3%   
Interest Rs m18435 527.5%   
Profit before tax Rs m7,4931,940 386.3%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568552 283.8%   
Profit after tax Rs m5,8441,387 421.3%  
Gross profit margin %22.215.4 144.1%  
Effective tax rate %20.928.5 73.5%   
Net profit margin %14.99.8 151.3%  
BALANCE SHEET DATA
Current assets Rs m19,57710,470 187.0%   
Current liabilities Rs m14,8962,749 541.9%   
Net working cap to sales %11.954.6 21.8%  
Current ratio x1.33.8 34.5%  
Inventory Days Days9055 162.6%  
Debtors Days Days4578 58.4%  
Net fixed assets Rs m27,0975,811 466.3%   
Share capital Rs m377167 225.6%   
"Free" reserves Rs m26,81114,248 188.2%   
Net worth Rs m27,18814,416 188.6%   
Long term debt Rs m4,9930-   
Total assets Rs m47,77817,649 270.7%  
Interest coverage x41.756.6 73.7%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.8 102.8%   
Return on assets %12.68.1 156.6%  
Return on equity %21.59.6 223.4%  
Return on capital %23.613.7 172.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,4536,164 315.6%   
Fx outflow Rs m6,0651,334 454.5%   
Net fx Rs m13,3884,829 277.2%   
CASH FLOW
From Operations Rs m8,1201,231 659.9%  
From Investments Rs m-7,556-208 3,630.9%  
From Financial Activity Rs m590-595 -99.2%  
Net Cashflow Rs m1,153427 270.0%  

Share Holding

Indian Promoters % 74.1 55.4 133.8%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 2.9 3.4 85.5%  
FIIs % 9.1 3.9 233.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 37.0 37.6%  
Shareholders   49,328 30,437 162.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   TORRENT PHARMA  NATCO PHARMA  ELDER PHARMA  SANOFI INDIA  ALKEM LABORATORIES  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday(Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS